GLAXOSMITHKLINE HAS lost the first round of its US court battle to defend more than pounds 1bn in annual sales of its most successful drug, the anti-depressant Paxil. GSK's army of salesmen are marketing a new controlled-release version of Paxil in the hope of switching as many patients as possible from the original before rivals become Cheap paxil established. By the end of this year, GSK will be growing again. GSK's shares, though, topped the FTSE 100 cheap paxil as Dr Garnier outlined faster- than-expected progress for its new treatments for psoriasis, breast cancer and neuropathic pain, which could be launched over the next few years. This was potentially very negative and that's been removed now for another six months, the analyst said. Glaxo continues to believe there cheap paxil are significant hurdles that prevent launch of a generic Paxil product, the company said. Both cheap paxil astrazeneca and GSK have multibillion-pound share buy-back programmes underway.

He said: We are elated with the ruling of Judge Posner and anticipate being able to bring this important drug to market no later than 2005. Analysts interpreted this to mean he would not risk launching before the outcome of the Philadelphia case, even if the drug receives regulatory approval at the earliest possible Cheap paxil date, 19 September. Three dozen drugs have passed proof of concept stage and will be in late-stage trials this year.

Cheap paxil this is looking one of the fattest in the industry. The premium to GSK shares is vast. At AstraZeneca it was the loss of Losec, an ulcer pill that cheap paxil once had sales of pounds 10m a day, which made 2003 a down year for profits. AstraZeneca's are too expensive.
GLAXOSMITHKLINE RAISED hopes it could head off potential rivals to one of its top-selling drugs yesterday and reassured investors by cheap paxil repeating its earnings guidance. They won't come of age until late in the decade, sure, but analysts will soon be plugging first guesses on potential sales into their forecasts for the future. Investors fear a repeat of the sales disaster which befell Eli Lilly, the US giant, when its drug Prozac faced competitors in 2001. Dr Garnier says 2004 is a transition year for GSK's product mix, Cheap paxil and it should also mark the company's transition from dog to darling. Steve Plag, pharmaceuticals analyst at Credit Suisse First Boston, said: This is clearly very good news as it means the second patent case now goes to trial in one of the slowest courts in the US, which should mean no resolution to the Paxil case until the end of 2003 at the earliest.
The shares rose 27p to 1,147p. AstraZeneca is proving more miserly, with a dividend yield below 2 per cent. Long- term winners could include another blockbuster asthma treatment being hailed as better cheap paxil than Advair, now GSK's best seller.

This entry was posted and is filed under Grapefruit Juice Lipitor . You can follow any responses to this entry through the Lexapro Maximum Dosage feed. Both comments and pings are currently closed.